CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 129 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $12,000 | -89.6% | 61,176 | -76.0% | 0.00% | -100.0% |
| Q3 2018 | $115,000 | +59.7% | 255,067 | +77.4% | 0.00% | 0.0% |
| Q2 2018 | $72,000 | -15.3% | 143,743 | +377.5% | 0.00% | 0.0% |
| Q4 2017 | $85,000 | -20.6% | 30,102 | -19.2% | 0.00% | -50.0% |
| Q3 2017 | $107,000 | -45.4% | 37,258 | -32.8% | 0.00% | -75.0% |
| Q4 2016 | $196,000 | -60.6% | 55,456 | -54.9% | 0.01% | -75.8% |
| Q3 2016 | $497,000 | +957.4% | 123,000 | +1049.5% | 0.03% | +1000.0% |
| Q2 2016 | $47,000 | -84.0% | 10,700 | -86.2% | 0.00% | -87.0% |
| Q1 2016 | $293,000 | – | 77,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |